Pear Therapeutics Reports the Availability of its Prescription Digital Therapeutics to Wellpath Community Care Centers
Shots:
- reSET and reSET-O are the 1st US FDA authorized PDTs for patients (aged ≥ 18 yrs.) with substance use disorder and opioid use disorder. The availability of PDT’s with outpatient care will elevate the nation’s battle against the substance and opioid use crisis
- Wellpath Community Care Centers can use Pear’s reSET and reSET-O products to provide same day- single-centered comprehensive medical and behavioral services (24/7) to optimize clinician delivered MAT for optimal outcomes
- reSET is indicated as a (90 day) prescription-only treatment for patients with SUD and reSET-O is intended to increase retention of patients with OUD in outpatient treatment by providing cognitive behavioral therapy
Ref: Pear Therapeutics | Image: Medical Product Outsourcing
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com